doi: 10.1016/j.micpath.2020.104303 130 LinCCChangTYLuYCWuYSHuangWLoWCet al
6-phosphogluconolactonase
Treatments tailored toward the needs of individual patients based on their CKD stage and microbiome profiles via the application of different -omics approaches such as microbiome analysis, metabolomics, metagenomics, metaproteomics, nutrigenomics, and others enable the application of suitable dietary requirements, physical activity, and/or biotic supplementation that will be most beneficial to them via modulation of the microbiota, reduction of uremic toxins and inflammation, and slowing CKD progression ultimately leading to an improvement in their cognitive health and overall quality of life
Gut bacteria metabolize carnitine into trimethylamine (TMA) , a compound with a characteristically fishy smell
These pharmacies are held to strict quality and safety standards, and they often use third-party testing to verify the purity and potency of every batch
Gastroenterology 132 , 21312157 (2007)